{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T14:36:35Z","timestamp":1782311795143,"version":"3.54.5"},"reference-count":63,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"49","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"S&T Program of Hebei","award":["H2021109008"],"award-info":[{"award-number":["H2021109008"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12,5]]},"abstract":"<jats:p>Thyroid cancer, particularly prevalent among women of childbearing age (WCBA), presents a growing global public health concern. This study examines the global, regional, and national burden of WCBA thyroid cancer from 1990 to 2021, with an emphasis on socioeconomic factors, including high body mass index. Data were drawn from the Global Burden of Diseases, Injuries, and Risk Factors Study 2021. We analyzed incidence, prevalence, disability-adjusted life years, and mortality rates for WCBA thyroid cancer, focusing on age-standardized rates. Temporal trends were quantified using the average annual percentage change. Inequalities were assessed using the concentration index; locally estimated scatterplot smoothing modeled age-standardized rate\u2013sociodemographic index (SDI) relationships; decomposition identified contributions of population growth, aging, and epidemiologic change. From 1990 to 2021, the global incidence of WCBA thyroid cancer increased with an average annual percent change (AAPC) of 1.4% (95% confidence interval [CI]: 1.32\u20131.48), while prevalence rose at an AAPC of 1.44% (95% CI: 1.37\u20131.52). Conversely, the age-standardized mortality rate declined annually by 0.28% (95% CI: \u22120.4 to \u22120.16), and disability-adjusted life years showed no significant change (AAPC\u2005=\u2005\u22120.01, 95% CI: \u22120.18 to 0.17). The highest increase in disease burden was observed in low and low-middle SDI regions, with mortality rates linked to high body mass index rising by 2.19% annually. In contrast, high-SDI regions experienced a decrease in burden, with annual reductions in mortality rates ranging from 1.13% to 0.34%. Rising WCBA thyroid cancer incidence and prevalence, particularly in low SDI regions, highlight the urgent need for targeted prevention and health management strategies.<\/jats:p>","DOI":"10.1097\/md.0000000000045930","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T22:00:47Z","timestamp":1764972047000},"page":"e45930","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Burden and trends of thyroid cancer among women of childbearing age, 1990\u20132021: A serial cross-sectional analysis"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9930-4535","authenticated-orcid":false,"given":"Hongzhou","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Aerospace Center Hospital, Beijing, China"},{"name":"Department of Endocrinology, First Hospital of Handan City, Handan, Hebei Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lang","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Hospital Infection Management and Preventive Health Care, Zhejiang Provincial People's Hospital Bijie Hospital, Bijie, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Aerospace Center Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangfan","family":"Du","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Aerospace Center Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Aerospace Center Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linlin","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Aerospace Center Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Aerospace Center Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Jin","sequence":"additional","affiliation":[{"name":"School of Biology and Engineering (School of Health Medicine Modern Industry), Guizhou Medical University, Guiyang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Liu","sequence":"additional","affiliation":[{"name":"School of Biology and Engineering (School of Health Medicine Modern Industry), Guizhou Medical University, Guiyang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Aerospace Center Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260523","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1089\/thy.2022.0501","article-title":"Infertility and pregnancy rates in female thyroid cancer survivors: a retrospective cohort study using health care administrative data from Israel.","volume":"33","author":"Hirsch","year":"2023","journal-title":"Thyroid"},{"key":"R2-20260523","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1001\/jamaoncol.2021.6987","article-title":"Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis for the global burden of disease study 2019.","volume":"8","author":"Kocarnik","year":"2022","journal-title":"JAMA Oncol"},{"key":"R3-20260523","doi-asserted-by":"crossref","first-page":"e214708","DOI":"10.1001\/jamanetworkopen.2021.4708","article-title":"Estimated projection of US cancer incidence and death to 2040.","volume":"4","author":"Rahib","year":"2021","journal-title":"JAMA Netw Open"},{"key":"R4-20260523","doi-asserted-by":"crossref","first-page":"e208759","DOI":"10.1001\/jamanetworkopen.2020.8759","article-title":"Global burden of thyroid cancer from 1990 to 2017.","volume":"3","author":"Deng","year":"2020","journal-title":"JAMA Netw Open"},{"key":"R6-20260523","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1089\/thy.2016.0457","article-title":"2017 guidelines of the american thyroid association for the diagnosis and management of thyroid disease during pregnancy and the postpartum.","volume":"27","author":"Alexander","year":"2017","journal-title":"Thyroid"},{"key":"R7-20260523","article-title":"Global, regional and national temporal trends in prevalence for musculoskeletal disorders in women of childbearing age, 1990-2019: an age-period-cohort analysis based on the Global Burden of Disease Study 2019.","volume":"83","author":"Cao","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"R8-20260523","doi-asserted-by":"crossref","first-page":"102713","DOI":"10.1016\/j.eclinm.2024.102713","article-title":"Global, regional, and national burden of female cancers in women of child-bearing age, 1990-2021: analysis of data from the global burden of disease study 2021.","volume":"74","author":"Sun","year":"2024","journal-title":"EClinicalMedicine"},{"key":"R9-20260523","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s10194-024-01798-z","article-title":"Global, regional, and national burden and trends of migraine among women of childbearing age from 1990 to 2021: insights from the Global Burden of Disease Study 2021.","volume":"25","author":"Cen","year":"2024","journal-title":"J Headache Pain"},{"key":"R10-20260523","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"R11-20260523","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S2213-8587(22)00035-3","article-title":"The epidemiological landscape of thyroid cancer worldwide: GLOBOCAN estimates for incidence and mortality rates in 2020.","volume":"10","author":"Pizzato","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R12-20260523","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1089\/thy.2019.0684","article-title":"Long-term declines of thyroid cancer mortality: an international age-period-cohort analysis.","volume":"30","author":"Li","year":"2020","journal-title":"Thyroid"},{"key":"R13-20260523","first-page":"12","article-title":"Cancer statistics, 2024.","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"R14-20260523","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S2213-8587(20)30401-0","article-title":"Global patterns and trends in incidence and mortality of thyroid cancer in children and adolescents: a population-based study.","volume":"9","author":"Vaccarella","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R15-20260523","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1016\/S0140-6736(24)00933-4","article-title":"Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"R16-20260523","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","article-title":"Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"R19-20260523","doi-asserted-by":"crossref","first-page":"103326","DOI":"10.1016\/j.autrev.2023.103326","article-title":"Global burden and cross-country inequalities in autoimmune diseases from 1990 to 2019.","volume":"22","author":"Cao","year":"2023","journal-title":"Autoimmun Rev"},{"key":"R20-20260523","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1001\/jamaoncol.2019.2996","article-title":"Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the global burden of disease study.","volume":"5","author":"Fitzmaurice","year":"2019","journal-title":"JAMA Oncol"},{"key":"R21-20260523","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/(SICI)1097-0258(19970415)16:7<791::AID-SIM500>3.0.CO;2-#","article-title":"Confidence intervals for directly standardized rates: a method based on the gamma distribution.","volume":"16","author":"Fay","year":"1997","journal-title":"Stat Med"},{"key":"R22-20260523","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","article-title":"Permutation tests for Joinpoint regression with applications to cancer rates.","volume":"19","author":"Kim","year":"2000","journal-title":"Stat Med"},{"key":"R23-20260523","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.1002\/sim.3733","article-title":"Estimating average annual per cent change in trend analysis.","volume":"28","author":"Clegg","year":"2009","journal-title":"Stat Med"},{"key":"R24-20260523","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/S0140-6736(18)32203-7","article-title":"Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017.","volume":"392","year":"2018","journal-title":"Lancet"},{"key":"R25-20260523","doi-asserted-by":"crossref","first-page":"103361","DOI":"10.1016\/j.autrev.2023.103361","article-title":"Global burden and risk factors of musculoskeletal disorders among adolescents and young adults in 204 countries and territories, 1990-2019.","volume":"22","author":"Guan","year":"2023","journal-title":"Autoimmun Rev"},{"key":"R26-20260523","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S2213-8587(20)30115-7","article-title":"Global trends in thyroid cancer incidence and the impact of overdiagnosis.","volume":"8","author":"Li","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R27-20260523","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1002\/ijc.31884","article-title":"Thyroid cancer \u201cepidemic\u201d also occurs in low- and middle-income countries.","volume":"144","author":"Lortet-Tieulent","year":"2019","journal-title":"Int J Cancer"},{"key":"R28-20260523","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1530\/ERC-19-0417","article-title":"Thyroid dysfunction and cancer incidence: a systematic review and meta-analysis.","volume":"27","author":"Tran","year":"2020","journal-title":"Endocr Relat Cancer"},{"key":"R29-20260523","doi-asserted-by":"crossref","first-page":"e2246311","DOI":"10.1001\/jamanetworkopen.2022.46311","article-title":"Association between genetic risk, adherence to healthy lifestyle behavior, and thyroid cancer risk.","volume":"5","author":"Feng","year":"2022","journal-title":"JAMA Netw Open"},{"key":"R30-20260523","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/s41574-020-00414-9","article-title":"Understanding the ever-changing incidence of thyroid cancer.","volume":"16","author":"Kitahara","year":"2020","journal-title":"Nat Rev Endocrinol"},{"key":"R31-20260523","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.eprac.2021.09.006","article-title":"Progress and challenges in thyroid cancer management.","volume":"27","author":"Haymart","year":"2021","journal-title":"Endocr Pract"},{"key":"R32-20260523","first-page":"119","article-title":"Modifiable risk factors for thyroid cancer: lifestyle and residence environment.","volume":"75","author":"Shen","year":"2024","journal-title":"Endokrynol Pol"},{"key":"R33-20260523","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1001\/jama.295.18.2164","article-title":"Increasing incidence of thyroid cancer in the United States, 1973-2002.","volume":"295","author":"Davies","year":"2006","journal-title":"JAMA"},{"key":"R34-20260523","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1001\/jama.2017.2719","article-title":"Trends in thyroid cancer incidence and mortality in the United States, 1974-2013.","volume":"317","author":"Lim","year":"2017","journal-title":"JAMA"},{"key":"R35-20260523","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ejca.2018.01.083","article-title":"The impact of overdiagnosis on thyroid cancer epidemic in Italy,1998-2012.","volume":"94","author":"Dal Maso","year":"2018","journal-title":"Eur J Cancer"},{"key":"R36-20260523","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1001\/jama.2017.4011","article-title":"Screening for thyroid cancer: US preventive services task force recommendation statement.","volume":"317","author":"Bibbins-Domingo","year":"2017","journal-title":"JAMA"},{"key":"R37-20260523","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1089\/thy.2020.0944","article-title":"2021 American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer.","volume":"31","author":"Bible","year":"2021","journal-title":"Thyroid"},{"key":"R38-20260523","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer.","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"issue":"Suppl 1","key":"R39-20260523","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/cen.12515","article-title":"Guidelines for the management of thyroid cancer.","volume":"81","author":"Perros","year":"2014","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R40-20260523","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0140-6736(08)60269-X","article-title":"Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies.","volume":"371","author":"Renehan","year":"2008","journal-title":"Lancet"},{"key":"R41-20260523","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1056\/NEJMsr1606602","article-title":"Body fatness and cancer--viewpoint of the IARC Working Group.","volume":"375","author":"Lauby-Secretan","year":"2016","journal-title":"N Engl J Med"},{"key":"R42-20260523","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S2213-8587(21)00027-9","article-title":"Thyroid cancer incidence trends by histology in 25 countries: a population-based study.","volume":"9","author":"Miranda-Filho","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R43-20260523","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s12020-022-03274-7","article-title":"Incidence and mortality of thyroid cancer in 50 countries: a joinpoint regression analysis of global trends.","volume":"80","author":"Huang","year":"2023","journal-title":"Endocrine"},{"key":"R44-20260523","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.beem.2011.07.010","article-title":"Thyroid disease in pregnancy.","volume":"25","author":"Negro","year":"2011","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"R45-20260523","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000354537","article-title":"2013 european thyroid association guidelines for cervical ultrasound scan and ultrasound-guided techniques in the postoperative management of patients with thyroid cancer.","volume":"2","author":"Leenhardt","year":"2013","journal-title":"Eur Thyroid J"},{"key":"R46-20260523","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ogc.2010.02.007","article-title":"Diagnosis and management of thyroid disease in pregnancy.","volume":"37","author":"Fitzpatrick","year":"2010","journal-title":"Obstet Gynecol Clin North Am"},{"key":"R47-20260523","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1093\/annonc\/mdz400","article-title":"Thyroid cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up.","volume":"30","author":"Filetti","year":"2019","journal-title":"Ann Oncol"},{"key":"R48-20260523","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1158\/1055-9965.EPI-13-0242","article-title":"The clinical and economic burden of a sustained increase in thyroid cancer incidence.","volume":"22","author":"Aschebrook-Kilfoy","year":"2013","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R49-20260523","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jss.2019.06.017","article-title":"Inverse relationship of BMI to TSH and risk of papillary thyroid cancer in surgical patients.","volume":"244","author":"Handelsman","year":"2019","journal-title":"J Surg Res"},{"key":"R50-20260523","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.ando.2021.09.002","article-title":"Thyroid cancer in the Democratic Republic of the Congo: frequency and risk factors.","volume":"82","author":"Bukasa Kakamba","year":"2021","journal-title":"Ann Endocrinol (Paris)"},{"key":"R51-20260523","doi-asserted-by":"crossref","first-page":"650117","DOI":"10.3389\/fonc.2021.650117","article-title":"Cancer in Africa: the untold story.","volume":"11","author":"Hamdi","year":"2021","journal-title":"Front Oncol"},{"key":"R52-20260523","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1111\/1759-7714.14099","article-title":"Global burden of thyroid cancer and its attributable risk factors in 204 countries and territories from 1990 to 2019.","volume":"12","author":"Bao","year":"2021","journal-title":"Thorac Cancer"},{"key":"R53-20260523","doi-asserted-by":"crossref","first-page":"4542","DOI":"10.1002\/cam4.3970","article-title":"The global burden of thyroid cancer and its attributable risk factor in 195 countries and territories: a systematic analysis for the Global Burden of Disease Study.","volume":"10","author":"Zhai","year":"2021","journal-title":"Cancer Med"},{"key":"R54-20260523","doi-asserted-by":"crossref","first-page":"e181","DOI":"10.1097\/AOG.0000000000002897","article-title":"ACOG Committee opinion no. 755: well-woman visit.","volume":"132","year":"2018","journal-title":"Obstet Gynecol"},{"key":"R55-20260523","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1089\/thy.2016.0100","article-title":"Systematic review of trends in the incidence rates of thyroid cancer.","volume":"26","author":"Wiltshire","year":"2016","journal-title":"Thyroid"},{"key":"R56-20260523","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"R57-20260523","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1089\/thy.2023.0370","article-title":"Social vulnerability association with thyroid cancer disparities in the United States.","volume":"34","author":"Fei-Zhang","year":"2024","journal-title":"Thyroid"},{"key":"R58-20260523","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1001\/jamaoto.2022.0660","article-title":"The cost and financial burden of thyroid cancer on patients in the US: a review and directions for future research.","volume":"148","author":"Uppal","year":"2022","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"R59-20260523","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1089\/thy.2019.0245","article-title":"Insurance status is associated with extent of treatment for patients with papillary thyroid carcinoma.","volume":"29","author":"Ullmann","year":"2019","journal-title":"Thyroid"},{"key":"R60-20260523","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1210\/jc.2005-2838","article-title":"Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy.","volume":"91","author":"Durante","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"R61-20260523","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/CM9.0000000000003008","article-title":"Pregnancy and the disease recurrence of patients previously treated for differentiated thyroid cancer: a systematic review and meta analysis.","volume":"137","author":"Shan","year":"2024","journal-title":"Chin Med J (Engl)"},{"key":"R62-20260523","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1089\/thy.2014.0343","article-title":"Reproductive outcomes and nononcologic complications after radioactive iodine ablation for well-differentiated thyroid cancer.","volume":"25","author":"Wu","year":"2015","journal-title":"Thyroid"},{"key":"R63-20260523","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1001\/jamainternmed.2019.4644","article-title":"Association between pregnancy outcomes and radioactive iodine treatment after thyroidectomy among women with thyroid cancer.","volume":"180","author":"Kim","year":"2020","journal-title":"JAMA Intern Med"},{"key":"R64-20260523","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0140-6736(22)01438-6","article-title":"The global burden of cancer attributable to risk factors, 2010-19: a systematic analysis for the Global Burden of Disease Study 2019.","volume":"400","year":"2022","journal-title":"Lancet"},{"key":"R65-20260523","doi-asserted-by":"crossref","first-page":"e1003198","DOI":"10.1371\/journal.pmed.1003198","article-title":"The global burden of disease attributable to high body mass index in 195 countries and territories, 1990-2017: an analysis of the Global Burden of Disease Study.","volume":"17","author":"Dai","year":"2020","journal-title":"PLoS Med"},{"key":"R66-20260523","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1186\/s12889-022-12601-6","article-title":"Overweight and obesity in non-pregnant women of childbearing age in South Africa: subgroup regression analyses of survey data from 1998 to 2017.","volume":"22","author":"Nglazi","year":"2022","journal-title":"BMC Public Health"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000045930","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T10:02:59Z","timestamp":1779530579000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000045930"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,5]]},"references-count":63,"journal-issue":{"issue":"49","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000045930","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,5]]},"assertion":[{"value":"2025-07-05","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-20","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}